Table 1.
Demographics and study-specific measures at the baseline visit. Measures are presented as the median and interquartile range (IQR), Q1–Q3.
| Variable | Probiotic Group | Placebo Group | p-Value 1 |
|---|---|---|---|
| Age (years, median (IQR)) | 5 (3–7) | 4 (3–6) | 0.284 |
| Weight (kg, median (IQR)) | 21 (18–25) | 20 (17–22) | 0.182 |
| Length (cm, median (IQR)) | 116 (102–126) | 109 (102–117) | 0.243 |
| IgA-tTG (U/mL, median (IQR))2 | 4.71 (1.58–12.21) | 4.38 (1.90–13.19) | 0.891 |
| IgG-tTG (U/mL, median (IQR)) 2 | 1.57 (1.11–4.74) | 1.60 (1.24–4.59) | 0.848 |
| First degree relative diagnosed with celiac disease (n (%)) | 6 (15.0) | 3 (7.9) | 0.334 |
| Use of foods/supplements fortified with probiotics before study start (n (%)) | 19 (48) | 18 (47) | 0.995 |
1 Wilcoxon signed rank test. Two-sided. 2 tTG -tissue transglutaminase.